GlassScriptPhysician profile
Douglas B Segal
NPI 1881660991
$24,271.88
in general payments reported to CMS, 2019-2025
32 companies · $5,790 in 2025
The $5,790 reported for 2025 was more than what 92% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,661 · 2020: $682 · 2021: $1,350 · 2022: $1,174 · 2023: $1,651 · 2024: $12K · 2025: $5,790.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $13K · Food and Beverage: $4,857 · Travel and Lodging: $1,286 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $13,250.00 |
| Food and Beverage | $4,856.79 |
| Travel and Lodging | $1,286.17 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16,746.47 | 2019-2025 | Lifevest |
| Abiomed | $1,389.54 | 2021-2025 | Impella |
| Shockwave Medical, INC | $817.29 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Bard Peripheral Vascular, INC. | $773.87 | 2023-2025 | Venclose Maven Catheter, Venovo |
| Medtronic, INC. | $569.30 | 2021-2025 | Micra, Venaseal |
| Merck Sharp & Dohme LLC | $503.25 | 2021-2025 | Verquvo, Capvaxive |
| Amgen INC. | $467.83 | 2019-2023 | Repatha |
| Janssen Pharmaceuticals, INC | $448.81 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $410.09 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $266.01 | 2019-2024 | Wainua |
| Boston Scientific Corporation | $222.04 | 2019-2025 | Rotapro |
| Medtronic Vascular, INC. | $177.79 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $167.94 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $161.19 | 2021-2025 | |
| Edwards Lifesciences Corporation | $136.89 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $120.60 | 2019-2021 | |
| Kestra Medical Technology Services, INC. | $117.92 | 2022-2024 | Assure Wcd |
| Scpharmaceuticals INC. | $106.61 | 2023-2025 | |
| Pfizer INC. | $100.60 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $96.59 | 2019-2023 | Camzyos |
| Abbott Laboratories | $89.11 | 2022-2025 | Aveir, Nc Trek Neo |
| Preventice Services, LLC | $80.87 | 2021 | |
| Cvrx, INC. | $49.93 | 2021-2024 | Barostim Neo System |
| Philips North America LLC | $42.90 | 2019-2023 | |
| Kiniksa Pharmaceuticals International, Plc | $42.14 | 2024 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $38.05 | 2023-2024 | Inpefa |
| Biotronik INC. | $27.52 | 2021 | |
| Inari Medical, INC. | $26.04 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Melinta Therapeutics, LLC | $20.45 | 2019 | |
| Glaxosmithkline, LLC. | $20.37 | 2025 | Shingrix |
| Regeneron Healthcare Solutions, INC. | $20.00 | 2019 | |
| Kiniksa Pharmaceuticals, LTD. | $13.87 | 2023 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Segal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.